Bayesian Capital Management’s Patterson-UTI PTEN Stock Holding History

Bayesian Capital Management’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.3K	Buy	+10,600	New	+$118K	0.06%	216
2025 Q3	–	Sell	-123,663	Closed	-$733K	–	754
2025 Q2	$733K	Buy	123,663 +80,200	+185%	+$483K	0.12%	223
2025 Q1	$357K	Sell	43,463 -81,437	-65%	-$683K	0.06%	353
2024 Q4	$1.03M	Buy	124,900 +71,100	+132%	+$570K	0.13%	224
2024 Q3	$412K	Buy	+53,800	New	+$496K	0.05%	416
2024 Q2	–	Sell	-52,200	Closed	-$623K	–	1024
2024 Q1	$623K	Buy	+52,200	New	+$580K	0.06%	393
2023 Q4	–	Sell	-22,700	Closed	-$314K	–	984
2023 Q3	$314K	Buy	+22,700	New	+$332K	0.04%	461
2019 Q4	–	Sell	-21,800	Closed	-$186K	–	718
2019 Q3	$186K	Buy	+21,800	New	+$214K	0.04%	455
2019 Q1	–	Sell	-23,100	Closed	-$239K	–	716
2018 Q4	$239K	Buy	+23,100	New	+$340K	0.05%	474
2018 Q2	–	Sell	-25,100	Closed	-$440K	–	692
2018 Q1	$440K	Buy	+25,100	New	+$524K	0.11%	299

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bayesian Capital Management's PTEN Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Patterson-UTI (PTEN) in Q2 2026: 10,600 shares worth $97.3K. The stake represents 0.06% of the portfolio and ranks #216 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in PTEN as recently as Q2 2025.

Bayesian Capital Management first reported a position in PTEN in Q1 2018 and has held it in 10 quarters since. The position peaked at $1.03M in Q4 2024. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

Bayesian Capital Management held 10,600 shares of Patterson-UTI worth $97.3K as of Q2 2026.
Patterson-UTI was a new Bayesian Capital Management position in Q2 2026.
Patterson-UTI made up 0.06% of Bayesian Capital Management's portfolio in Q2 2026, its #216 holding.
Bayesian Capital Management first reported a position in Patterson-UTI in Q1 2018 and has held it in 10 quarters since.
Bayesian Capital Management's Patterson-UTI position peaked at $1.03M in Q4 2024.
438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.